Walbrook PR Welcomes LungLife AI To AIM
08 July 2021
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces it has acted as Financial PR & Investor Relations advisor for the AIM IPO of LungLife AI plc (AIM: “LLAI”), a developer of clinical diagnostic solutions for the early detection of lung cancer enhanced by artificial intelligence. The team at Walbrook will now manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.